Clinical aspects of Clostridium difficile infection after initiation of anti tuberculous medicatio
Not Applicable
Recruiting
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0000808
- Lead Sponsor
- Konyang University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Clostridium difficile infection patients who were administrated anti-TB medications
Definition of CDI
: Documented diarrhea and any positive outcome ( one or more)
in the following diagnostic tests.
CD toxin A and/or B by enzyme immunoassay (EIA)
Positive stool culture for C.difficile
Typical endoscopic findings, such as multiple white or yellow plaques
Exclusion Criteria
Patients who has not been recorded variables.
Patients who has been administered any antibioitcs (except anti-TB medications), within a month from the start of CDI.
Patients who follow up loss
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of C.difficile infection after TB medication;Association between C. difficile infection and rifampicin
- Secondary Outcome Measures
Name Time Method clinical manifestations, lab findings, imaging findins